Mass Tort brief
Uber Bellwether Settles as Paraquat Herbicide Deals Collapse
Rideshare passenger assault claims and agricultural herbicide litigation hit pivotal settlement turning points across federal multidistrict courts.
Mass Tort
More than 900 Parkinson's patients rejected Syngenta and Chevron settlement terms — collapsing efforts to quietly wrap up the herbicide docket.
BackgroundParaquat is a potent commercial herbicide linked in scientific studies to cellular damage that triggers Parkinson's disease in chronically exposed farmworkers. Federal lawsuits allege that chemical manufacturers hid neurological risks and failed to mandate adequate protective gear on product labels.
- Plaintiffs' attorneys stated that proposed financial compensation formulas drastically undervalued ongoing in-home nursing and specialized neurological care, sparking mass client rejections.
- Syngenta had reserved hundreds of millions to resolve approximately 8,400 claims, but mass rejections threaten to derail the global resolution framework.
- The widespread pushback increases pressure on the presiding federal judge to schedule new bellwether trials or remand cases back to home districts.
Mass Tort
Becton Dickinson failed to dismiss the third PowerPort lawsuit — advancing another high-exposure trial after a $40M jury loss.
BackgroundBard PowerPort devices are surgically implanted vascular access ports designed to allow repeated intravenous delivery of chemotherapy drugs and nutrients. More than 4,140 patients have filed federal product liability lawsuits alleging excessive barium sulfate in the polyurethane compromised catheter strength.
- Plaintiff May Lattanzio alleges material breakdown in her implanted port caused catastrophic bacterial infections and vascular tissue degradation, requiring emergency surgical intervention.
- The ruling follows a $40 million jury verdict awarded to a plaintiff in the second bellwether trial involving fractured catheter tubing.
- U.S. District Judge David Campbell ruled that expert testimony demonstrating material degradation is legally sufficient to go to a jury, closing Bard's primary defense.
Mass Tort
Uber settled its third bellwether suit right after jury selection — avoiding a public verdict that could force a multi-billion-dollar global settlement.
BackgroundThousands of passengers have filed lawsuits against Uber alleging that negligent driver screening and defective background-check systems allowed dangerous drivers to remain active. Multidistrict litigation consolidates these federal personal injury claims before Senior U.S. District Judge Charles Breyer in California.
- Uber stipulated during jury selection that it would not dispute the sexual assault occurred, focusing its defense entirely on platform liability boundaries.
- The driver had been convicted in criminal court and sentenced to 11 years in prison for the 2020 assault, leaving Uber little room to contest liability.
- MDL co-lead counsel argued that settling on the courthouse steps highlights Uber's reluctance to test driver screening procedures before a federal jury.
Mass Tort
Federal mass tort litigation sits above 204,000 cases — as surging youth social media and device lawsuits offset Bayer's Roundup resolutions.
BackgroundThe Judicial Panel on Multidistrict Litigation consolidates complex civil actions involving common questions of fact into single federal district courts to streamline discovery and pre-trial motions. The monthly caseload report provides a comprehensive snapshot of corporate legal liability across product and environmental torts.
- Bayer's pending Roundup docket shrank from 3,925 to 1,104 lawsuits as private settlement payouts continued to close legacy claims, clearing court dockets.
- Excluding Roundup resolutions, the federal mass tort inventory expanded by 1,671 new personal injury lawsuits during September, driven by youth mental health suits.
- The fastest-growing dockets include youth social media mental health claims against tech platforms and rideshare sexual assault lawsuits against Uber and Lyft.
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
